{
    "id": 14413,
    "cites": 3,
    "cited_by": 0,
    "reference": [
        "K. Gifford, S. Kramer and L. Elam. The transition of dual eligibles to Medicare part d prescription drug coverage: State actions during implementation. Results from a 50-state snapshot 9. Stuart B. Where are the Medicare Part D claims data? Annals of Internal Medicine. 2008;148:l-2.",
        "Potential Problems with the Transition of Dual-Eligible Beneficiaries from Medicaid to Medicare Drug Coverage, GAO-06278R, Transmitted from GAO to Senate Finance Committee on December 16, 2005 by letter from Kathleen M. King, Director, Health Care, GAO to Senator Max Baucus.",
        "Basu A, Zhang J, Rabbani A, Meltzer DO, Alexander GC. Impact of the Medicare Part D Prescription Drug Benefit on drug utilization and out-of-pocket expenditures. Annals of Internal Medicine. 2008;148:169-177; Lichtenberg F, Sun S. The impact of Medicare Part D on prescription drug use by the elderly: evidence from a large retail pharmacy chain. Health Aff 2007;26:1735-1744; Frank RG, Newhouse JP. Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How? Health Aff 2008;27 (1 ) : 33-43."
    ]
}